Amicus Therapeutics, Inc. logo

FOLDAmicus Therapeutics, Inc.

FOLD Stock Price, Valuation & Chart | Amicus Therapeutics, Inc.

Compare

FOLD Historical price chart

FOLD Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization4.55B
PE Ratio-161.0
EPS-0.09
Trading Volume0
Today's High/Low14.49/14.49
Dividend Yield0.00
52 Week High/Low14.5/5.51
Shares Outstanding314.00M
FOLD Financial Statement
FOLD Analyst ratings
FOLD Analysis & performance metrics

FOLD Company profile

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product…

FOLD Management team

Management
Bradley L. Campbell M.B.A.CEO
Chief Executive Officer, President & Director
Diana Moore
Head of Global Corporate Communications
Simon Nicolas Reade HarfordCFO
Chief Financial Officer
David M. Clark
Chief People Officer
Samantha L. Prout
Chief Accounting Officer & Controller
Ellen S. Rosenberg J.D.
Chief Legal Officer & Corporate Secretary
Andrew Faughnan
Vice President of Investor Relations
Jill Weimer Ph.D.
Chief Science Officer
Total 8 executives

FOLD Frequently asked questions

What is Amicus Therapeutics, Inc. (FOLD) Stock Price?

Current stock price of Amicus Therapeutics, Inc. (FOLD) stock is $14.490. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Amicus Therapeutics, Inc. (FOLD) stock is 0.

Last updated at 27 Apr 2026, 08:00 pm.

Why is the Amicus Therapeutics, Inc. (FOLD) stock price going up or down today?

The stock price of Amicus Therapeutics, Inc. (FOLD) can change with earnings, company news, and overall market sentiment. Amicus Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Amicus Therapeutics, Inc. stock expensive at its current price?

Whether Amicus Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for FOLD on this page is -161.00. EPS on this page is -0.09. Compare those figures with peers and growth expectations before deciding if the current Amicus Therapeutics, Inc. price is justified.

How has the stock price of Amicus Therapeutics, Inc. (FOLD) performed historically?

Historical performance for Amicus Therapeutics, Inc. (FOLD) is shown on the price chart on this page. Review multi-period moves alongside volume to see how FOLD reacted to past earnings and market events.

Should I buy Amicus Therapeutics, Inc. (FOLD) stock, at this price?

Buying Amicus Therapeutics, Inc. (FOLD) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.